Stijn van Rompay

Stijn van Rompay

Fortuna: 38 M $ al 30/09/2026

50 años
Health Technology
Consumer Services
Electronic Technology

Perfil

Stijn van Rompay was the founder of Uteron Pharma SA, founded in 2010, where the title held was General Manager from 2010 to 2015.
Mr. van Rompay is the founder of Hyloris Pharmaceuticals SA, founded in 2012, holding the title Chief Executive Officer & Executive Director starting in 2025.
Mr. van Rompay is also the founder of Alter Pharma Group NV.
Current jobs include Director at ImCyse SA since 2012, Managing Director & Director at EXO Biologics SA since 2019, and Managing Director & Director at Hyloris Developments SA since 2020.
Former jobs include Non-Executive Director at Coalesce Product Development Ltd. and Chief Financial Officer at Docpharma NV.
Education includes graduate degree from the University of Antwerp.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 7.743.067 ( 27,65 % ) 38 M $ 30/09/2026

Cargos activos de Stijn van Rompay

EmpresasCargoInicio
HYLORIS PHARMACEUTICALS SA Fundador 01/01/2012
Director/Miembro de la Junta 01/01/2012
Director/Miembro de la Junta 29/08/2019
Director Ejecutivo 20/04/2020

Antiguos cargos conocidos de Stijn van Rompay.

EmpresasCargoFin
Director/Miembro de la Junta 27/09/2024
Director Ejecutivo 01/08/2015
Fundador -
Director Ejecutivo -
Ver el detalle de la experiencia de Stijn van Rompay.

Formación de Stijn van Rompay.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

33

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Consumer Services

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Stijn van Rompay